G779-0620 Screening compound: 3-{3-[1-(4-chlorobenzyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1,2,4-oxadiazol-5-yl}-N~1~-(3-pyridylmethyl)propanamide

G779-0620 Screening compound: 3-{3-[1-(4-chlorobenzyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1,2,4-oxadiazol-5-yl}-N~1~-(3-pyridylmethyl)propanamide
G779-0620 Screening compound: 3-{3-[1-(4-chlorobenzyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1,2,4-oxadiazol-5-yl}-N~1~-(3-pyridylmethyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G779-0620
3-{3-[1-(4-chlorobenzyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1,2,4-oxadiazol-5-yl}-N~1~-(3-pyridylmethyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G779-0620

Molecular Formula

C23H24ClN5O2 (C23 H24 ClN5 O2)

Compound Name

3-{3-[1-(4-chlorobenzyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1,2,4-oxadiazol-5-yl}-N~1~-(3-pyridylmethyl)propanamide

IUPAC name

3-(3-{1-[(4-chlorophenyl)methyl]-1236-tetrahydropyridin-4-yl}-124-oxadiazol-5-yl)-N-[(pyridin-3-yl)methyl]propanamide

SMILES

O=C(CCc1nc(C2=CCN(Cc(cc3)ccc3Cl)CC2)no1)NCc1cnccc1

InChI

InChI=1S/C23H24ClN5O2/c24-20-5-3-17(4-6-20)16-29-12-9-19(10-13-29)23-27-22(31-28-23)8-7-21(30)26-15-18-2-1-11-25-14-18/h1-6,9,11,14H,7-8,10,12-13,15-16H2,(H,26,30)

InChI Key

MXUCKBVPTJDUSA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15035476

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.93

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.001

Distribution Coefficient, logD

2.982

Water Solubility, LogSw

-3.50

Polar Surface Area

69.032

Acid Dissociation Constant (pKa)

13.80

Base Dissociation Constant (pKb)

6.05

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.43

G779-0620 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G779-0620 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G779-0620?
Check Price and Availability of G779-0620, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G779-0620 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G779-0620
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G779-0620
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G779-0620 available by request